 |
|
|
| |
Real-Life Effectiveness, Safety, and Acceptance of Long-Acting
Cabotegravir-Rilpivirine: Results from a large single center cohort
|
| |
| |
Glasgow 2024 Nov 15-19
Ana González-Cordón*, Montserrat Laguno, Leire Berrocal, Maria Martínez-Rebollar, Berta Torres, Ivan Chivite, Alexy Inciarte, Paula Arreba, Juan Ambrosioni, Alberto Foncillas, Lorena de la Mora, José Luis Blanco, Júlia Calvo, Esteban Martinez, Abiu Sempere, Josep M Miro, Roger Llobet, Elisa de Lazzari, Josep Mallolas Infectious Diseases - HIV Unit, Hospital Clínic - IDIBAPS - University of Barcelona, Barcelona, Spain; CIBERINFEC, ISC-III, Madrid, Spain *(agonzal1@clinic.cat)
|
| |
|
|
|
|
|
